VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 140 filers reported holding VIKING THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $951,799 | -82.3% | 85,980 | -74.0% | 0.00% | -80.0% |
Q2 2023 | $5,364,246 | -62.1% | 330,922 | -61.1% | 0.01% | -66.7% |
Q1 2023 | $14,153,416 | +58.3% | 850,055 | -10.6% | 0.02% | +50.0% |
Q4 2022 | $8,941,656 | +23430.7% | 951,240 | +6760.2% | 0.01% | – |
Q3 2022 | $38,000 | -24.0% | 13,866 | -19.8% | 0.00% | – |
Q2 2022 | $50,000 | -90.5% | 17,300 | -90.2% | 0.00% | – |
Q1 2022 | $529,000 | +445.4% | 176,278 | +983.3% | 0.00% | – |
Q2 2021 | $97,000 | -20.5% | 16,273 | -15.4% | 0.00% | – |
Q1 2021 | $122,000 | -12.2% | 19,239 | -22.3% | 0.00% | – |
Q4 2020 | $139,000 | -59.7% | 24,765 | -58.2% | 0.00% | – |
Q3 2020 | $345,000 | -35.8% | 59,257 | -20.5% | 0.00% | -100.0% |
Q2 2020 | $537,000 | +62.2% | 74,517 | +5.3% | 0.00% | 0.0% |
Q1 2020 | $331,000 | +203.7% | 70,798 | +422.8% | 0.00% | – |
Q4 2019 | $109,000 | -77.2% | 13,541 | -50.6% | 0.00% | -100.0% |
Q3 2018 | $478,000 | -50.6% | 27,426 | -73.1% | 0.00% | 0.0% |
Q2 2018 | $967,000 | – | 101,846 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |